Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys

Am J Transplant. 2021 Jan;21(1):161-173. doi: 10.1111/ajt.16148. Epub 2020 Jul 5.

Abstract

Thousands of kidneys from higher-risk donors are discarded annually because of the increased likelihood of complications posttransplant. Given the severe organ shortage, there is a critical need to improve utilization of these organs. To this end, normothermic machine perfusion (NMP) has emerged as a platform for ex vivo assessment and potential repair of marginal organs. In a recent study of 8 transplant-declined human kidneys on NMP, we discovered microvascular obstructions that impaired microvascular blood flow. However, the nature and physiologic impact of these lesions were unknown. Here, in a study of 39 human kidneys, we have identified that prolonged cold storage of human kidneys induces accumulation of fibrinogen within tubular epithelium. Restoration of normoxic conditions-either ex vivo during NMP or in vivo following transplant-triggered intravascular release of fibrinogen correlating with red blood cell aggregation and microvascular plugging. Combined delivery of plasminogen and tissue plasminogen activator during NMP lysed the plugs leading to a significant reduction in markers of renal injury, improvement in indicators of renal function, and improved delivery of vascular-targeted nanoparticles. Our study suggests a new mechanism of cold storage injury in marginal organs and provides a simple treatment with immediate translational potential.

Keywords: basic (laboratory) research/science; coagulation and hemostasis; disease pathogenesis; kidney biology; kidney transplantation/nephrology; thrombolytic therapy/thrombolysis; translational research/science; vascular biology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Kidney
  • Kidney Transplantation* / adverse effects
  • Organ Preservation*
  • Perfusion
  • Tissue Plasminogen Activator

Substances

  • Tissue Plasminogen Activator